A Duane Reade by Walgreens drug store is in the Oculus Transportation Hub at the World Trade Center. New York State will receive more than $1 billion from negotiated agreements with Teva, CVS and Walgreens. Photo: Ted Shaffrey/AP
A “complex and unprecedented” slate of previously announced settlements between a number of states and CVS, Walgreens and manufacturers Allergan and Teva Pharmaceuticals for those companies’ roles in fueling the national opioid epidemic have been finalized, the jurisdictions said Friday.
An additional $18.75 billion will now be provided to communities throughout the country to address the epidemic, according to the National Prescription Opiate Litigation Plaintiffs’ Executive Committee, which partnered with a number of state attorneys general, including in New York, California and Connecticut, to resolve the matter.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
